Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death is a research paper published in Theranostics (2022). On theSindex it has a DataRank of 0.736. It has been cited 134 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.736
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
11.05
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity
Additional file 1 of Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity
Additional file 1 of Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light
Additional file 1 of Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light
Additional file 2 of Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light
Additional file 2 of Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light
Additional file 1 of In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
Additional file 1 of In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
Additional file 1 of Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
Additional file 1 of Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
Additional file 1 of Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
Additional file 1 of Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy